Seegene outlines expansion strategies at AACC 2022

By LabPulse.com staff writers
July 29, 2022

Seegene provided a glimpse of its global expansion initiatives at the 2022 American Association of Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo in Chicago, held July 26-28.

At AACC, the company displayed its fully automated Starlet-Aios (all-in-one system) for which it has obtained the CE-IVDR Mark.

The system enables hands-free PCR workflows and integrates syndromic assays that can test for multiple targets using a single test tube. Its modular design enables small hospitals, local clinics, and public health centers to integrate it into their workflows, the firm said.

Seegene also displayed its Novaplex product line for the U.S. market, which includes a test for detecting the monkeypox virus. The company said it recently strengthened its leadership team as part of the company's efforts to expand into the U.S. market.

The South Korea-based firm also noted that it recently obtained EU approval for more than 30 tests that can detect COVID-19 and other respiratory illnesses, human papillomavirus (HPV), other sexually transmitted infections, gastrointestinal infections, and drug resistance.If you like this content, please share it with a colleague!

Seegene secures EU approval for SARS-CoV-2 assay
South Korea-based molecular diagnostics company Seegene has secured European Union approval for its Allplex SARS-CoV-2/FluA/FluB/RSV assay.
Seegene unveils strategy for $12 COVID-19 PCR tests
South Korea-based molecular diagnostics company Seegene has unveiled a global initiative for preemptive and routine COVID-19 PCR testing that the company...
Seegene develops '3 Ct' assay for HPV infection
South Korea-based molecular diagnostics company Seegene announced the development of a polymerase chain reaction assay that uses three-cycle threshold...
Seegene Novaplex PCR assays speed up SARS-CoV-2 detection
Seegene Technologies’ Novaplex SARS-CoV-2 polymerase chain reaction (PCR) assays can quickly and reliably detect SARS-CoV-2 in patient samples, according...
Seegene taps Creager to lead U.S. business
Richard Creager, PhD, has been named CEO of Seegene's U.S. subsidiary Seegene Technologies. He will lead the unit's activities ranging from research and...

Copyright © 2022 LabPulse.com

Last Updated mp 7/29/2022 12:18:05 PM